v3.25.2
SCHEDULE OF BUSINESS SEGMENT (Details) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Segment Reporting Information [Line Items]      
Total assets $ 47,011,380   $ 41,708,071
Total revenue 3,169,920 $ 7,180  
Net loss (616,458) (1,503,990)  
Net income loss (867,603) (159,450)  
Interest expense (889,792) (301,912)  
HealthCares [Member]      
Segment Reporting Information [Line Items]      
Total assets 46,790,560   41,399,346
Total revenue 3,161,431  
Net loss (844,598)  
Labs and Life [Member]      
Segment Reporting Information [Line Items]      
Total assets 16,503   26,646
Total revenue 8,489 7,180  
Net loss (23,005) (159,450)  
Corporate Segment and Other Operating Segment [Member]      
Segment Reporting Information [Line Items]      
Total assets 204,317   $ 282,079
Total revenue [1]  
Net loss [1] 1,140,937 (1,042,628)  
Interest Expense [Member]      
Segment Reporting Information [Line Items]      
Total revenue [1]  
[1] For the three months ended March 31, 2025, Corporate and other includes a $1.9 million gain from extinguishment of Senior PIK Notes, stock-based compensation, including amortization of consulting fees paid in stock, of $0.1 million and depreciation and amortization expense of $2,257. For the three months ended March 31, 2024, Corporate and other includes stock-based compensation, including amortization of consulting fees paid in stock, of $0.1 million and depreciation and amortization expense of $0.3 million.